Inspire Medical Systems Inc (INSP) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.88x

Inspire Medical Systems Inc (INSP) has a Cash Flow Reinvestment Rate of 0.88x as of March 2026, reinvesting $11.25 Million (capex $9.73 Million plus investments $-1.52 Million) from operating cash flow of $12.85 Million. Check INSP cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.88x
(Capex + Investments) / Operating CF

Total Reinvested

$11.25 Million
Capex + Investments

Operating Cash Flow

$12.85 Million
USD

Capital Expenditures

$9.73 Million
USD

Inspire Medical Systems Inc Cash Flow Reinvestment Rate (2022–2025)

Historical reinvestment intensity for Inspire Medical Systems Inc across 4 annual periods. Explore INSP long-term investments to assets to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Inspire Medical Systems Inc (2022–2025)

Year-by-year capital reinvestment analysis for Inspire Medical Systems Inc. For live market cap and broader valuation context, see Inspire Medical Systems Inc market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.84x $98.44 Million $116.98 Million $38.50 Million ▼ -28.0%
2024 1.17x $152.25 Million $130.25 Million $39.12 Million ▼ -83.0%
2023 6.88x $169.68 Million $24.65 Million $23.63 Million ▲ +306.3%
2022 1.69x $19.60 Million $11.57 Million $9.10 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow